9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Cellectar Biosciences, Inc.
Nuvation Bio Inc.
Turning Point Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
Bristol-Myers Squibb
AbbVie
Shenzhen BinDeBio Ltd.
INSYS Therapeutics Inc